# Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial

> **NCT04948749** · NA · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 792 (estimated)

## Conditions studied

- ICAD - Intracranial Atherosclerotic Disease
- ICAS - Intracranial Atherosclerosis
- Drug-eluting Stent
- Stroke
- Drug Eluting Stents (DES)
- Medical Treatment

## Interventions

- **DEVICE:** Drug Eluting Stent implantation
- **DRUG:** Aggressive medical treatment
- **BEHAVIORAL:** Risk factor management
- **DRUG:** Standard medical treatment

## Key facts

- **NCT ID:** NCT04948749
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-02
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 792 (ESTIMATED)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04948749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04948749, "Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04948749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*